- Public Comps
- Vext Science
Vext Science Valuation Multiples
Discover revenue and EBITDA valuation multiples for Vext Science and similar public comparables like Planet 13, WM Tech, Little Green Pharma, Leef Brands and more.
Vext Science Overview
About Vext Science
Vext Science Inc provides management, advisory, cultivation, and dispensary services to entities in the medical cannabis field. The company’s expertise spans from cultivation through to retail operations. Its revenue sources include management fees, professional services, product sales, equipment leasing and property leasing. The company’s operations consist of a single operating segment engaged in the cultivation, manufacturing, distribution and sale of cannabis within the United States.
Founded
2015
HQ

Employees
228
Website
Financials (LTM)
EV
$76M
Valuation Multiples
Start free trialVext Science Financials
Vext Science reported last 12-month revenue of $61M and EBITDA of $14M.
In the same LTM period, Vext Science generated $14M in EBITDA and had net loss of ($10M).
Vext Science P&L
In the most recent fiscal year, Vext Science reported revenue of $51M and EBITDA of $5M.
Vext Science is unprofitable as of last fiscal year, with gross margin of 28%, EBITDA margin of 10%, and net margin of (35%).
Financial data powered by Morningstar, Inc.
Vext Science Stock Performance
Vext Science has current market cap of $48M, and enterprise value of $76M.
Vext Science's stock price is $0.19.
Vext Science has an EPS (earnings per share) of $-0.07.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $76M | $48M | 0.1% | - | - | - | $-0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialVext Science Valuation Multiples
Vext Science trades at 1.3x EV/Revenue multiple, and 5.5x EV/EBITDA.
Vext Science Financial Valuation Multiples
As of August 14, 2026, Vext Science has market cap of $48M and EV of $76M.
Vext Science has a P/E ratio of (4.7x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Vext Science Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Vext Science Margins & Growth Rates
Vext Science grew revenue by 30% and EBITDA by 203% in the last fiscal year.
In the most recent fiscal year, Vext Science reported gross margin of 28%, EBITDA margin of 10%, and net margin of (35%).
Vext Science Margins
Vext Science Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Vext Science Operational KPIs
Vext Science's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Vext Science's Rule of 40 is 53% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Vext Science's Rule of X is 98% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Vext Science Competitors
Vext Science competitors include Planet 13, WM Tech, Little Green Pharma, Leef Brands, ZYUS Life Sciences, MariMed, iAnthus Capital Holdings, Rubicon Organics, Mountain Valley MD Hldgs and Peak Processing.
Most Vext Science public comparables operate across Cannabis, CannaTech and ViceTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.9x | 1.0x | (5.4x) | (18.5x) | |||
| 0.0x | 0.0x | 0.3x | 0.3x | |||
| 1.5x | 1.0x | 24.0x | 8.0x | |||
| 1.8x | - | (6.1x) | - | |||
| 152.3x | - | (3.7x) | - | |||
| 0.7x | 0.7x | 13.4x | 6.7x | |||
| 1.7x | - | 14.0x | - | |||
| 0.7x | 0.6x | 8.1x | 7.5x | |||
This data is available for Pro users. Sign up to see all Vext Science competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Vext Science
| When was Vext Science founded? | Vext Science was founded in 2015. |
| Where is Vext Science headquartered? | Vext Science is headquartered in United States. |
| How many employees does Vext Science have? | As of today, Vext Science has over 228 employees. |
| Is Vext Science publicly listed? | Yes, Vext Science is a public company listed on OTCM. |
| What is the stock symbol of Vext Science? | Vext Science trades under VEXTF ticker. |
| When did Vext Science go public? | Vext Science went public in 2019. |
| Who are competitors of Vext Science? | Vext Science main competitors include Planet 13, WM Tech, Little Green Pharma, Leef Brands, ZYUS Life Sciences, MariMed, iAnthus Capital Holdings, Rubicon Organics, Mountain Valley MD Hldgs, Peak Processing. |
| What is the current market cap of Vext Science? | Vext Science's current market cap is $48M. |
| What is the current revenue of Vext Science? | Vext Science's last 12 months revenue is $61M. |
| What is the current revenue growth of Vext Science? | Vext Science revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Vext Science? | Current revenue multiple of Vext Science is 1.3x. |
| What is the current EBITDA of Vext Science? | Vext Science's last 12 months EBITDA is $14M. |
| What is Vext Science's EBITDA margin? | Vext Science's last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Vext Science? | Current EBITDA multiple of Vext Science is 5.5x. |
| What is the current FCF of Vext Science? | Vext Science's last 12 months FCF is $9M. |
| What is Vext Science's FCF margin? | Vext Science's last 12 months FCF margin is 15%. |
| What is the current EV/FCF multiple of Vext Science? | Current FCF multiple of Vext Science is 8.6x. |
| How many companies Vext Science has acquired to date? | Vext Science hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Vext Science has invested to date? | Vext Science hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Vext Science
Lists including Vext Science
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




